Literature DB >> 2759186

The effect of organ culture on human trabecular meshwork.

D H Johnson1, R C Tschumper.   

Abstract

The effect of organ culture on the trabecular meshwork was studied in a series of human eyes using a perfusion culture system. One eye of a pair was cultured while the fellow eye was immediately fixed in glutaraldehyde. Culture periods ranged from 2 to 28 days, during which a mean intraocular pressure of 27 mmHg +/- 15 was maintained. The perfused culture medium appeared to leave the eye via Schlemm's canal and collector channels, mimicking the in vivo situation. The trabecular meshwork was well maintained with this system in 21 of 25 eyes. Cells remained in position on trabecular lamellae, cellular organelles usually remained normal, and the lamellae remained intact. Culture-induced changes were noted, with some cells developing intracytoplasmic lipid vacuoles and other cells developing swollen mitochondria. In addition, scattered focal cell necrosis was observed, most often in the uveal meshwork. Meshwork cellularity (nuclei:solid tissue) was determined with an image analysis system; there was an average cell loss of 20-40% in the cultured eyes as compared to their respective fellow control eyes. Overall, organ culture appears to maintain the human trabecular meshwork for at least 28 days, allowing controlled experimental studies to be performed.

Entities:  

Mesh:

Year:  1989        PMID: 2759186     DOI: 10.1016/0014-4835(89)90080-8

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  27 in total

1.  In situ autofluorescence visualization of human trabecular meshwork structure.

Authors:  James C H Tan; Jose M Gonzalez; Sarah Hamm-Alvarez; Jonathan Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

2.  Targeted gene transfer to Schlemm's canal by retroperfusion.

Authors:  W Daniel Stamer; D W-H Chan; C Ross Ethier
Journal:  Exp Eye Res       Date:  2007-01-14       Impact factor: 3.467

3.  Two-photon immunofluorescence characterization of the trabecular meshwork in situ.

Authors:  Jose M Gonzalez; Martin Heur; James C H Tan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

4.  Effects of cyclic intraocular pressure on conventional outflow facility.

Authors:  Renata F Ramos; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

Review 5.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

6.  Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids.

Authors:  Thania Bogarin; Sindhu Saraswathy; Goichi Akiyama; Xiaobin Xie; Robert N Weinreb; Jie Zheng; Alex S Huang
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

7.  Effects of Hydrogen Sulfide-Releasing Compounds on Aqueous Humor Outflow Facility in Porcine Ocular Anterior Segments, Ex Vivo.

Authors:  Jenaye Robinson; Esther Okoro; Chinoso Ezuedu; Leah Bush; Catherine A Opere; Sunny E Ohia; Ya Fatou Njie-Mbye
Journal:  J Ocul Pharmacol Ther       Date:  2017-01-18       Impact factor: 2.671

8.  Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments.

Authors:  Cindy K Bahler; Kyle G Howell; Cheryl R Hann; Michael P Fautsch; Douglas H Johnson
Journal:  Am J Ophthalmol       Date:  2007-11-07       Impact factor: 5.258

Review 9.  Model systems for the study of steroid-induced IOP elevation.

Authors:  Ilya Rybkin; Rosana Gerometta; Gabrielle Fridman; Oscar Candia; John Danias
Journal:  Exp Eye Res       Date:  2016-07-20       Impact factor: 3.467

10.  Bimatoprost, prostamide activity, and conventional drainage.

Authors:  Zhou Wan; David F Woodward; Clive L Cornell; Hans G Fliri; José L Martos; Simon N Pettit; Jenny W Wang; Alexander B Kharlamb; Larry A Wheeler; Michael E Garst; Kari J Landsverk; Craig S Struble; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.